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High throughput analysisAbstract The reaction of 2,3-dichloro-1,4-naphthoquinone (DCNQ) with crizotinib (CZT; a novel
drug used for treatment of non-small cell lung cancer) was investigated in different solvents of vary-
ing dielectric constants and polarity indexes. The reaction produced a red-colored product. Spectro-
photometric investigations conﬁrmed that the reaction proceeded through charge–transfer (CT)
complex formation. The molar absorptivity of the complex was found to be linearly correlated with
the dielectric constant and polarity index of the solvent; the correlation coefﬁcients were 0.9567 and
0.9069, respectively. The stoichiometric ratio of DCNQ:CZT was found to be 2:1 and the associa-
tion constant of the complex was found to be 1.07 · 102 l/mol. The kinetics of the reaction was stud-
ied; the order of the reaction, rate and rate constant were determined. Computational molecular
modeling for the complex between DCNQ and CZT was conducted, the sites of interaction on
CZT molecule were determined, and the mechanism of the reaction was postulated. The reaction
was employed as a basis in the development of a novel 96-microwell assay for CZT in a linear range
76 N.Z. Alzoman et al.of 4–500 lg/ml. The assay limits of detection and quantitation were 2.06 and 6.23 lg/ml, respec-
tively. The assay was validated as per the guidelines of the International Conference on Harmoni-
zation (ICH) and successfully applied to the analysis of CZT in its bulk and capsules with good
accuracy and precision. The assay has high throughput and consumes a minimum volume of
organic solvents thus it reduces the exposures of the analysts to the toxic effects of organic solvents,
and signiﬁcantly reduces the analysis cost.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The charge–transfer (CT) reaction has considerable impor-
tance in different chemistry ﬁelds because of its presence in
biological systems (Bolton et al., 1991; Kuznetsov and
Ulstrup, 1999), widespread applications as organic electrical
conductors (Eychimu¨ller and Rogach, 2000; Singh et al.,
2010), in studying drug-receptor interaction mechanisms
(Pandeeswaran and Elango, 2009), storage of solar energy
(Takahasi et al., 1993), and studying the thermodynamics
and pharmacodynamics of drug molecules (Taboada et al.,
2003; Pandeswaran and Elango, 2010). CT reactions usually
produce intensely colored CT complexes with a new light
absorption band that has longer kmax than that of the CT com-
plex components (Atkins and Shriver, 1999; Foster, 1969; Rao,
1975). The rapid formation of these complexes leads to their
widespread utility in the development of spectrophotometric
methods for an analysis of many organic and/or pharmaceuti-
cal molecules (El-Bagary et al., 2011, 2012; Kalyanaramu
et al., 2011; Darwish et al., 2005). For these reasons, extensive
studies involving CT reactions have been conducted (Dutta
et al., 2008; Rappaport, 1963; Pandeeswaran et al., 2009;
Nudelman et al., 1999; Fakhroo et al., 2010; Roy et al.,
1999). The naphthoquinone derivatives have p-orbitals of the
naphthoquinone ring, which have electron afﬁnity. The intro-
duction of electron-withdrawing groups like chloro-, nitro-,
cyano, etc., on the naphthoquinone ring increases this electron
afﬁnity (Chatterjee, 1971). These groups have strong electro-
negativity and large Hammett constants (Saito and
Matsunaga, 1971). 2,3-Dichloro-1,4-naphthoquinone (DCNQ)
acts as a strong p-electron acceptor in studying the CT reac-
tions of electron donors (Saha et al., 2008; Datta and
Mukherjee, 2004).
Crizotinib (CZT) is a novel small-molecule; inhibitor of
tyrosine kinases. CZT was granted an accelerated approval
by the FDA on August 26, 2011 (under the trade name of
Xalkori capsules made by Pﬁzer, Inc.) for the treatment of
patients with advanced local or metastatic non-small cell lung
cancer (NSCLC) carrying anaplastic lymphoma kinase (ALK)
fusion gene (Kris, 2010; FDA, 2011). Extensive literature sur-
vey revealed that the electron-donating properties of CZT and
its CT reactions have not been investigated yet. As well, there
was no existing analytical method for pharmaceutical quality
control (QC) of CZT. These facts were behind our interest in
investigating the CT reaction of CZT with DCNQ and
employment of the reaction in the development of a new pho-
tometric method for QC of CZT.
In this study, CT reaction between CZT and DCNQ was
investigated and the reaction was employed in the development
of a novel 96-microwell spectrophotometric assay for CZT. In
this assay, the CT reaction was carried out in 96-microwellassay plates and absorbances of the CT complex solutions
were measured by a microwell-plate absorbance reader.
2. Experimental
2.1. Apparatus
UV-1601 PC double-beam spectrophotometer (Shimadzu,
Kyoto, Japan) was used for recording the absorption spectra.
Microwell-plate absorbance reader (Spectramax M5, Molecu-
lar Devices, California, USA) empowered by Spectramax M5
software (provided with the instrument). RIA/EIA assay
plates were a product of Corning/Costar Inc. (Cambridge,
USA).
2.2. Chemicals and materials
Crizotinib (CZT) standard was obtained from Haoyuan
Chemexpress Co., Ltd. (Shanghai, China) and used as
received; the purity of the investigated compound was
>99%. DCNQ (Sigma–Aldrich Corporation, St. Louis, MO,
USA). Xalkori Capsules (Pﬁzer Inc., New York, NY,
USA) labeled to contain 250 mg CZT per Capsule. Solvents
and pharmaceutical excipients were of analytical grade (Fisher
Scientiﬁc, California, CA, USA).
2.3. Preparation of standard CZT solutions
Into a 5-ml calibrated ﬂask, 10 mg (2.22 · 105 mol) of CZT
was dissolved in 2 ml methanol, and the solution was com-
pleted to volume with the same solvent. This stock solution
(4.44 · 103 M) was diluted with the appropriate solvent to
obtain CZT concentrations suitable for each corresponding
study.
2.4. Determination of association constant
A series of CZT solutions (0.23 · 104 to 1.14 · 104 M) were
mixed with DCNQ solution of a ﬁxed concentration
(2.28 · 103 M); both CZT and DCNQ solutions were pre-
pared in ethanol. These mixed solutions were allowed to reach
equilibrium (90 min) at room temperature (25 ± 2 C). The
absorbance of the solutions was measured at 490 nm against
reagent blanks treated similarly.
2.5. Determination of CZT:DCNQ molar ratio
Master solutions of CZT (0.25 · 102 M) and DCNQ
(2 · 102 M) were prepared; DCNQ molar concentration was
8-fold that of CZT. A series of the master solutions of CZT
(A)
(C)
(B)
Figure 1 Panel (A): absorption spectra of CZT (1.14 · 104 M)
against methanol. Panel (B): absorption spectra of DCNQ
(2.28 · 103 M), and its reaction mixtures with CZT
(4.4 · 104 M) measured at varying time intervals (5–90 min)
against the reagent blank. Panel (C): absorption spectra of
reaction mixtures containing a ﬁxed concentration of DCNQ
(2.28 · 103 M) and varying CZT concentrations (1.78 · 104 to
8.88 · 104 M) against reagent blank. All DCNQ and CZT were
prepared in methanol.
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concentration (0.25 · 102 M) and varying DCNQ concentra-
tions (0.25 · 102 to 2 · 102 M); CZT:DCNQ molar ratio
was 1:8. The reaction was carried out at room temperature
(25 ± 2 C) for 45 min. The absorbances of the reaction solu-
tions were measured at 490 nm against blanks treated similarly
except ethanol was used instead of CZT sample. The measured
absorbances were plotted as a function of CZT:DCNQ molar
ratio. The generated plot was used for determination of the
molar ratio of the reaction between CZT and DCNQ.
2.6. Computational modeling for the CT complex of CZT with
DCNQ
The molecular modeling for the CT complex was performed by
using CS Chem3D Ultra, version 9 (Cambridge Soft Corpora-
tion, Cambridge, MA, USA) implemented with molecular
orbital computations software (MOPAC), and molecular
dynamics computations software (MM2).
2.7. Preparation of CZT capsule sample solution
The contents of 10 capsules were weighed and a quantity of the
capsule content equivalent to 20 mg of CZT was transferred
into a 10-ml calibrated ﬂask, dissolved in 4 mL ethanol,
swirled and sonicated for 5 min, completed to volume with
the ethanol, shaken well for 15 min, and ﬁltered. The ﬁrst por-
tion of the ﬁltrate was rejected, and a measured volume of the
ﬁltrate was diluted with ethanol to yield CZT concentrations in
the range of 8–1000 lg/ml.
2.8. Microwell assay procedure
Accurately measured aliquots (100 ll) of the standard or sample
solution containing varying amounts of CZT (8–1000 lg/ml)
were transferred into wells of 96-microwell assay plates. One
hundred microliters of DCNQ solution (0.5%, w/v) was
added, and the reaction was allowed to proceed at room tem-
perature (25 ± 2 C) for 45 min. The absorbances of the
resulting solutions were measured at 490 nm by the micro-
well-plate reader. Blank wells were treated similarly except
100 ll of ethanol was used instead of the sample, and the
absorbances of the blank wells were subtracted from those of
the other wells.
3. Results and discussion
3.1. Absorption spectral characteristics
The absorption spectrum of CZT solution (1.14 · 104 M, in
methanol) was recorded (Fig. 1A). It is obvious from the spec-
trum that CZT has two maximum absorption peaks (kmax) at
270 and 320 nm. The CZT solution was mixed with DCNQ
solution (2.28 · 103 M, in methanol), and the interaction of
CZT with DCNQ was carried out at room temperature
(25 ± 2 C), and the absorption spectrum of the reaction mix-
ture was recorded against DCNQ reagent blank solution
(Fig. 1B). A red-colored product was obtained showing
absorption maximum at 488 nm. The absorption intensity of
this new absorption maximum increased with time (Fig. 1B)and increase in CZT concentrations in the interaction solution
(Fig. 1C). This gradual continuous increase in the new absorp-
tion band with the reaction time and CZT concentrations was
indicative of the formation of CZT-DCNQ product. The new
absorption band was due to the electron transfer from CZT
(D) to DCNQ (electron acceptor; A) accompanied by the
formation of colored radical acceptor anion (DCNQ––)
78 N.Z. Alzoman et al.(Taha and Ru¨cker, 1977), which was formed by the dissocia-
tion of an original donor–acceptor (D–A) complex:
DþA +( ðD–AÞ +(
polar solvent
Dþ þA
This dissociation was promoted by the high ionizing power
of the polar solvent (Taha and Ru¨cker, 1977).
3.2. Effect of solvent on the interaction of DCNQ with CZT
The interaction of DCNQ with CZT was allowed to proceed in
different solvents of varying dielectric constants and polarity
indexes and the absorption spectra were recorded (Fig. 2A);
the maximum absorption peaks (kmax) and molar absorptivity
(e) were determined in each solvent. Shifts in the kmax value
were observed, and the e values were also inﬂuenced; the
obtained values are given in Table 1. The interaction in polar
solvents with high dielectric constants (e.g., ethanol) produced
more intense higher e values than those produced in solvents
with low polar indexes and dielectric constants (e.g., 1,4-diox-
ane); however the reaction did not proceed at all in non-polarY = 0.0.0909 + 0.0.0273 X  
(r = 0.9567) 
Y = -0.9889 + 0.3947 X  
(r = 0.9069) 
(B)
(A)
Figure 2 Panel (A): absorption spectra of reaction mixtures of
DCNQ (2.28 · 103 M) and CZT (4.44 · 104 M) in different
solvents. Solvents were: chloroform (1), 1,4-dioxane (2), dichlo-
roethane (3), dichloromethane (4), propane-2-ol (5) and ethanol
(6). Panel (B): the plot of molar absorptivity (e) of DCNQ-CZT
complex versus dielectric constant (d) and polarity index (4) of
the solvent and the ﬁtting linear equations.solvent (chloroform). The values of e were correlated with both
the dielectric constants (Vogel, 1989) and polarity indexes
(Polarity Index, 2014) of the solvent in which the reaction
was performed (Fig. 2B); correlation coefﬁcients were
(r) = 0.9567 and 0.9069 for dielectric constants and polarity
indexes, respectively. This was due to the electron transfer
from CZT (electron donor; D) to DCNQ (electron acceptor;
A) that takes place in the polar solvents. Among all the sol-
vents tested, ethanol was selected for subsequent experiments
because it offered the most intense (highest e value) complexes.
This was due to the high dielectric constant of ethanol that
promotes a maximum yield of radical anion of DCNQ.
3.3. Molar ratio of the reaction, computational modeling of the
CT complex, determination of the sites of interaction and
proposing the reaction mechanism
The molar ratio of CZT to DCNQ was determined and it was
found that the CZT:DCNQ ratio was 1:2. This indicated that
two sites of interaction on CZT molecule involved in the for-
mation of the colored CT complex with DCNQ and two
DCNQ molecules were required for formation of the complex.
For investigating these two possible sites of interaction and
explaining the reaction pathway, modeling for the CT complex
was conducted. The electron density on each atom of CZT
molecule was calculated. As well, one CZT molecule and two
DCNQ molecules were energy-minimized alone and together.
It was found that the electron densities located on the nitrogen
atom of the primary amino group (NH2) attached to the pyr-
idine ring and the nitrogen atom of the piperidine ring are the
highest electron densities among all CZT atoms. These densi-
ties were 0.45561 and 0.39580, respectively; the negative signs
indicate the negative electron densities. As shown in pose
depicted in Fig. 3, one DCNQ molecule was found near the
primary amino group (NH2) attached to the pyridine ring
and the other DCNQ molecule found near the nitrogen atom
of the piperidine ring. These observations, taking the molar
ratio into account, suggested that the nitrogen atom of the pri-
mary amino group (NH2) attached to the pyridine ring and the
nitrogen atom of the piperidine ring are the electron-donating
sites on CZT molecules those involved in the formation of CT
complex with DCNQ. The other anticipated centers did not
contribute in the CT reaction based on the fact that certain
electron density was required for achievement of a successful
electron transfer (Foster, 1969). Based on these results, the
CT reaction of CZT with DCNQ was postulated to proceed
as described in Fig. 4.
3.4. Kinetic study for the formation of DCNQ-CZT CT complex
The interaction of DCNQ with CZT was carried out at room
temperature (25 ± 2 C) and the absorbance-time curves for
the reaction of varying CZT concentrations (0.23 · 10–4 to
1.14 · 10–4 M) with a ﬁxed concentration of DCNQ
(2.28 · 10–3 M) were generated (Fig. 5A). The initial reaction
rates (K) were determined from the slopes of these curves.
The logarithms of the reaction rate (logK) were plotted as a
function of logarithms of CZT concentrations (logC)
(Fig. 5B).
The regression analysis for the values was performed by ﬁt-
ting the data to the following equation:
Table 1 Effect of solvents on the position and intensity of absorption of the reaction mixture of DCNQ (2.28 · 103 M) with CZT
(4.44 · 104 M).
Solvent Dielectric constant Polarity index kmax e (·103)
Acetonitrile 37.5 5.7 490 1.23
Methanol 32.7 5.1 488 0.86
Ethanol 24.6 5.2 490 1.42
Acetone 20.7 5.1 495 0.89
Dichloromethane 10.5 3.5 492 0.49
Toluene 2.4 2.4 489 0.23
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Figure 3 Energy-minimized CZT and its CT complex with two
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Figure 4 Scheme for the CT reaction pathway of CZT with
DCNQ.
Charge–transfer reaction of 2,3-dichloro-1,4-naphthoquinone with crizotinib 79logK ¼ logk0 þ n logC ð1Þ
where K is reaction rate, k0 is the rate constant, C is the molar
concentration of CZT, and n (slope of the regression line) is the
order of the reaction. A straight line with slope values of
0.9824 (1) was obtained conﬁrming that the reaction was ﬁrst
order. However under the reaction conditions, the concentra-
tion of DCNQ was in large excess compared to that of CZT
in the reaction solution. Therefore, the reaction was regarded
as a pseudo-ﬁrst order reaction.
The absorbance-time curves at different temperatures (25–
60 C) were generated (Fig. 6A) using ﬁxed concentration of
CZT (1.14 · 10–4 M) and DCNQ (2.28 · 10–3 M). From these
curves the apparent rate constants were calculated. The activa-
tion energy, deﬁned as the minimum kinetic energy that a mol-
ecule possesses in order to undergo a reaction, was determined
using Arrhenius equation (Martin et al., 2004):
logk ¼ logA Ea=2:303RT ð2Þ
where k is the apparent rate constant, A is the frequency fac-
tor, Ea is the activation energy, T is the absolute temperature
(C+ 273), and R is the gas constant (1.987 calories/degree/
mole). The values of logk were plotted as a function of 1/T.
Straight lines with slope (=Ea/2.303R) value of 921.394
was obtained (Fig. 6B). From these value data, the activation
energy was calculated and found to be 4.2 kcal/mol. This low
activation energy explained that the reaction between DCNQand CZT was not strongly dependent on the temperature
and DCNQ could be used as a useful chromogenic derivatiza-
tion reagent for the development of a sensitive spectrophoto-
metric assay for the determination of CZT.
3.5. Association constant for the CZT-DCNQ CT complex
The association constant was evaluated at room temperature
(25 ± 2 C) and at the kmax of CZT–DCNQ complex using
(A)
(B)
Y = 1.4300 + 1.0532 X  
(r = 0.9824) 
Figure 5 Panel (A): the absorption-time curves for the reaction
of DCNQ (2.28 · 103 M) with varying concentrations of CZT;
these concentrations were: 0.23 · 104 (d), 0.46 · 104 (4),
0.89 · 104 (m), 0.91 · 104 (s), and 1.14 · 104 (¤) M. All
solutions were prepared in ethanol and the reactions were carried
out at room temperature (25 ± 2 C). Panel (B): linear plot for log
C vs. log K for the kinetic reaction of DCNQ (2.28 · 103 M) with
varying concentrations of CZT (0.23 · 104 to 1.14 · 104 M). C
and K are the CZT concentration (M) and the reaction rate (s1),
respectively.
Temp. (° C) 
(A)
Y = -0.5273 – 921.394 X  
(r = 0.9966) 
(B)
Figure 6 Panel A: absorbance-time curves of reaction mixtures
containing ﬁxed concentrations of CZT (0.46 · 104 M) with
DCNQ (2.28 · 10–3 M) at different temperatures. Panel B: Arrhe-
nius plot for the reaction of CZT with DCNQ at varying
temperatures.
Figure 7 Benesi–Hildebrand plot of CT complex of DCNQ with
CZT and the linear ﬁtting equation. [Ao], A
AD and [D0] are the
molar concentration of DCNQ, absorbance of the complex
reaction mixture, and molar concentration of CZT, respectively.
All solutions were prepared in ethanol and the reactions were
carried out at room temperature (25 ± 2 C).
80 N.Z. Alzoman et al.the Benesi–Hildebrand equation (Benesi and Hildebrand,
1949):
Ao
AAD
¼ 1
eAD
þ 1
KADc  eAD
 1½Do ð3Þ
where [Ao] is the molar concentration of the acceptor (DCNQ);
[Do] is the molar concentration of the donor (CZT); A
AD is the
absorbance of the complex formed at the kmax; e
AD is the molar
absorptivity of the complex;KcAD is the association constant of
the complex (l/mole). Upon plotting the values [Ao]/A
AD versus
l/[Do], a straight line was obtained (Fig. 7), fromwhich the asso-
ciation constant, correlation coefﬁcient, and the molar absorp-
tivity (e) of the CZT–DCNQ complex were calculated. The
intercept of the ﬁtting line was corresponding to 1/eAD and
the association constant was calculated from the slope value
of the line and the derived value of eAD. The molar absorptivity
and association constant of the complex were found to be
6.49 · 103 l/mole/cm and 1.07 · 102 l/mole, respectively. The
relative low value of the association constant was attributed
to the common feature for CT complexes with p-acceptors
because of the dissociation of the original donor–acceptor com-
plex to the radical anion (Foster, 1969).3.6. Development of microwell assay
3.6.1. Strategy for the assay development and it design
Based on the aforementioned successful formation of a red CT
complex between CZT and DCNQ, the reaction was attempted
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ric assay for the pharmaceutical quality control (QC) of CZT.
The conventional CT-based spectrophotometric methods have
low throughput. In addition, these methods consume large vol-
umes of organic solvents, which lead to high analysis cost, and
more importantly, the incidence of exposure of the analysts to
the toxic effects of the organic solvents (Fidler et al., 1987;
Wennborg et al., 2000, 2002; Lindbohm et al., 2007;
Kristensen et al., 2008). Reduction of human exposure to
organic solvents is one of the main objectives of hygienists,
public authorities, World Health Organization, environment
protection agencies, and occupational safety and health
administrations. For these reasons, investigating new alterna-
tive methodological approaches to reduce the consumption
of organic solvents in CT-based photometric analysis is very
important. Therefore, the present research was devoted to
employ the CT reaction of CZT in the development of novel
non-conventional photometric method with high analysis
throughput and can reduce the consumption of organic sol-
vents in the QC of CZT.
In previous studies (Darwish et al., 2010, 2012, 2013) a
microwell plate reader equipped with spectrophotometric
detection has employed in the development of high-throughput
photometric assays for measuring the active drug contents in
pharmaceutical preparations. For these reasons, the present
study was designed to employ this methodology for CZT;
the reaction was carried out in 96-microwell plates (200 ll vol-
ume). For high throughput analysis, the solutions were dis-
pensed by 8-chanel pipette, and the absorbances were
measured by a plate reader, which was able to read the 96 well
simultaneously in 30 s.
3.6.2. Optimization of assay conditions
The conditions for carrying out the reaction in the 96-micro-
well assay plate were optimized by altering each reaction var-
iable in a turn while keeping the others constant. The studied
conditions were: concentration of DCNQ reagent, reaction
time, and temperature. The studied range of these conditions
and the optimum value that was selected for the assay develop-
ment are given in Table 2.
3.7. Validation of the assay
3.7.1. Linearity and sensitivity
Calibration curve for the analysis of CZT by the proposed
assay was constructed and it was found that Beer’s law plot
(8-concentration levels, n= 5) was linear in the range of 4–
500 lg mL1. The limits of detection (LOD) and quantitationTable 2 Optimization of experimental conditions for the
microwell spectrophotometric assay for CZT based on its
formation of colored CT complex with DCNQ.
Condition Studied range Optimum
DCNQ conc. (%, w/v) 0.01–1 0.5
Solvent Diﬀerenta Ethanol
Reaction time (min) 0–90 45
Temperature (C) 25–60 25
kmax (nm) 400–600 490
a Solvents used were given in Table 1.(LOQ) were determined (ICH Guideline, 2005) and found to
be 3.96 and 12.00 lg/ml, respectively. The quantitative param-
eters of the proposed microwell assay are given in Table 3.
3.7.2. Precision
The intra- and inter-assay precision was assessed and the cal-
culated relative standard deviations (RSD) were 0.95–1.74
and 1.48–1.78 in case of intra- and inter-assay precision,
respectively (Table 4). These low RSD values proved the high
precision of the assay for the routine application in quality
control laboratories for determination of CZT.
3.7.3. Accuracy, selectivity and interference liabilities
The accuracy of the proposed assay was assessed by the recov-
ery studies for varying CZT concentrations (Table 4). The
recovery values were 98.64–101.53 ± 1.45–2.12% (Table 5),
indicating the accuracy of the proposed assay. Before proceed-
ing with the analysis of CZT in its dosage forms (capsules),
interference liabilities were carried out to explore the effect
of inactive ingredients that might be added during CZT cap-
sules formulation (Xalkori, 2013). Samples were prepared by
mixing a known amount (250 mg) of CZT with 50 mg of
microcrystalline cellulose, 10 mg of colloidal silicon dioxide,
5 mg of anhydrous dibasic calcium phosphate, 5 mg of sodium
starch glycolate, and 5 mg of magnesium stearate. These labo-
ratory-prepared samples were analyzed by the proposed
method applying the general recommended procedure. The
recovery values ranged from 96.50–101.69 ± 0.31–1.76%
(Table 5). These data conﬁrmed the absence of interference
from any of the inactive ingredients with the determination
of CZT by the proposed assay.
3.7.4. Robustness and ruggedness
Robustness was examined by evaluating the inﬂuence of small
variation in the assay variables on its analytical performance.
In these experiments, one parameter was changed whereas
the others were kept unchanged, and the recovery percentage
was calculated each time. It was found that small variation
in the method variables did not signiﬁcantly affect the proce-
dures; recovery values ranged from 97.12–102.14 ± 1.05–
1.82% (Table 7). This indicated the reliability of the proposed
assay for routine application for the analysis of CZT.
Ruggedness was also tested by applying the proposed meth-
ods to the assay of CZT using the same operational conditions
but using two different instruments at two different laboratories
and different elapsed time. Results obtained from lab-to-lab andTable 3 Quantitative parameters for the analysis of CZT by
the microwell spectrophotometric assay based on the CT
reaction of CZT with DCNQ.
Parameter Value
Linear range (lg/ml) 4–500
Intercept 0.0005
Standard deviation of intercept 2.4 · 103
Slope 0.0002
Standard deviation of slope 1.2 · 106
Correlation coeﬃcient 0.9999
LOD (lg/ml) 3.96
LOQ (lg/ml) 12.00
Table 4 Precision of the proposed assay at different CZT
concentration levels.
Concentration (lg/ml) Relative standard deviation
Intra-assay, n= 5 Inter-assay, n= 3
25 1.52 1.75
50 1.45 1.62
100 1.03 1.48
200 0.95 1.55
400 1.65 1.78
Table 5 Recovery study for determination of CZT by the
proposed microwell spectrophotometric assay.
Concentration (lg/ml) Recovery (%± SD) a
Taken Measured
25 24.88 99.52 ± 1.85
50 50.55 101.10 ± 1.18
100 101.53 101.53 ± 1.45
200 198.64 99.32 ± 2.12
400 394.57 98.64 ± 2.05
a Values are mean of three determinations.
Table 6 Analysis of CZT in presence of the excipients those
are present in its capsules by the proposed microwell spectro-
photometric assay.
Excipient Recovery (%± SD)a
Microcrystalline cellulose (50)b 100.94 ± 1.72
Colloidal silicon dioxide (10) 98.40 ± 1.73
Anhydrous dibasic calcium phosphate (5) 101.69 ± 0.48
Sodium starch glycolate (5) 96.50 ± 1.76
Magnesium stearate (5) 99.43 ± 0.31
a Values are mean of three determinations.
b Figures in parenthesis are the amounts (in mg) that were added
per 250 mg of CZT.
Table 7 Robustness and ruggedness of the proposed micro-
well spectrophotometric assay for determination of CZT.
Parameters Recovery (%± SD) a
Robustness
DCNQ concentration (%, w/v)
0.4 97.12 ± 1.28
0.6 99.48 ± 1.09
Reaction time (min)
40 101.65 ± 1.82
50 102.14 ± 1.47
Temperature ( C)
23 98.77 ± 1.63
28 100.85 ± 1.05
Ruggedness
Instrument to-instrumentb
Instrument-1 98.45 ± 1.09
Instrument-2 99.82 ± 1.84
Day-to-day
Day-1 101.62 ± 1.81
Day-2 97.94 ± 1.25
Day-3 102.46 ± 1.94
a Values are the mean of three determinations ± SD.
b Instruments 1 and 2 were Spectramax M5 (Molecular Devices,
California, USA) and ELx 808 (Bio-Tek Instruments Inc., USA),
respectively.
82 N.Z. Alzoman et al.day-to-day variationswere reproducible, as theRSDvalues ran-
ged from 97.94–102.46 ± 1.09–1.94% (Table 6).
3.8. Application of the proposed assay in the analysis of CZT
capsules
The CZT-containing capsules were subjected to the analysis by
the proposed assay for their CZT content. The mean percent-
age recovery, relative to the labeled amounts, obtained by the
proposed assay was 98.19 ± 0.86%. This good recovery values
indicated the reliability of the proposed assay for routine
application for the accurate determination of CZT in pharma-
ceutical QC laboratories.
4. Conclusions
The present study described, for the ﬁrst time, the CT reaction
between DCNQ and CZT. The DCNQ:CZT ratio was 2:1 and
the formation constant of the CT complex was determined.
The molar absorptivity of the complex was sensitive to thechange in dielectric constant and polarity index of the solvent.
The electron donating sites on CZT molecule was determined
by the computational molecular modeling for the CT complex,
and the reaction mechanism was postulated. The reaction was
employed as a basis for new microwell spectrophotometric
assay for determination of CZT in its capsules. The assay pro-
vided a high analytical throughput that can facilitate the pro-
cessing of a large number of samples in a relatively short time.
This property was attributed to the use of multi-channel pip-
ettes for efﬁcient dispensing of the solutions, carrying out the
analytical reaction in 96-well plates (as reaction vessels), and
measuring the color signals in the 96 wells at 30 s by the plate
reader. In addition, the assay can reduce the consumption of
organic solvents, accordingly reduction in the exposures of
the analysts to the toxic effects of organic solvents, and reduc-
tion in the analysis cost when applied in pharmaceutical qual-
ity control laboratories.
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